Advertisement
Robert Gasparini, the Company's President and Chief Scientific Officer,and Steven Jones, the Company's Chief Financial Officer, will give a 23-minutepresentation regarding NeoGenomics' market positioning, financial performance,and strategic direction. The presentation will be webcast LIVE featuringhigh-definition, streaming video and PowerPoint slides. Access is availableby logging on to the conference website www.noblemadmax.com or directly viahttp://hosted.mediasite.com/hosted4/Viewer/?peid=d1e3b760-7d83-4d0a-86c1-82908ba4ba0c. In addition, a portal to the webcast will be available in theInvestor Relations section of the NeoGenomics' website. It is recommendedthat interested parties register at least 10 minutes prior to the start of thepresentation to ensure timely access to the webcast.
Advertisement
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratorythat specializes in cancer genetics diagnostic testing, the fastest growingsegment of the laboratory industry. The company's testing services includecytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry,morphology studies, anatomic pathology and molecular genetic testing.Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN,Irvine, CA and Fort Myers and services the needs of pathologists, oncologists,urologists, and hospitals throughout the United States. For additionalinformation about NeoGenomics, visit http://www.neogenomics.org .
About Noble Financial
Noble Financial is a privately-held, full-service capital markets firmdriven by what is often overlooked by other firms -- uncovering the valueembedded in the orphaned, undiscovered or misunderstood company. The companyfocuses on converting market inefficiencies into profit opportunities. NobleFinancial supports emerging companies through strategic advice, investmentbanking, market-making, sales & trading, comprehensive equity research, andthe development of institutional support. Noble Financial's equity conferences-- 2008 marks their fourth annual -- allow for a unique blend of professionaland personal interaction among a diverse cross-section of executives. Thecompany has operated for 24 years and has offices in Florida, New York Cityand Boston.Interested parties can also access additional investor relations materialfrom the American Microcap Institute athttp://www.americanmicrocapinstitute.com/ngnm/ or from Hawk Associates athttp://www.hawkassociates.com. An investment profile about NeoGenomics may befound athttp://www.hawkassociates.com/clients/additional/index.cfm?client_id=10.
SOURCE NeoGenomics, Inc.
